BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27832277)

  • 1. Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus.
    Sardell RJ; Persad PJ; Pan SS; Whitehead P; Adams LD; Laux RA; Fortun JA; Brantley MA; Kovach JL; Schwartz SG; Agarwal A; Haines JL; Scott WK; Pericak-Vance MA
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6107-6115. PubMed ID: 27832277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
    Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
    Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different hereditary contribution of the CFH gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han people.
    Huang L; Li Y; Guo S; Sun Y; Zhang C; Bai Y; Li S; Yang F; Zhao M; Wang B; Yu W; Zhao M; Khor CC; Li X
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2534-8. PubMed ID: 24692129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
    Seddon JM; Francis PJ; George S; Schultz DW; Rosner B; Klein ML
    JAMA; 2007 Apr; 297(16):1793-800. PubMed ID: 17456821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.
    Awh CC; Hawken S; Zanke BW
    Ophthalmology; 2015 Jan; 122(1):162-9. PubMed ID: 25200399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Hyperreflective Foci Present in Early Forms of Age-Related Macular Degeneration With Known Age-Related Macular Degeneration Risk Polymorphisms.
    Altay L; Scholz P; Schick T; Felsch M; Hoyng CB; den Hollander AI; Langmann T; Fauser S
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4315-20. PubMed ID: 27552409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.
    Wegscheider BJ; Weger M; Renner W; Steinbrugger I; März W; Mossböck G; Temmel W; El-Shabrawi Y; Schmut O; Jahrbacher R; Haas A
    Ophthalmology; 2007 Apr; 114(4):738-42. PubMed ID: 17398321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.
    Goverdhan SV; Hannan S; Newsom RB; Luff AJ; Griffiths H; Lotery AJ
    Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
    Awh CC; Lane AM; Hawken S; Zanke B; Kim IK
    Ophthalmology; 2013 Nov; 120(11):2317-23. PubMed ID: 23972322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
    Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
    Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism.
    Shuler RK; Hauser MA; Caldwell J; Gallins P; Schmidt S; Scott WK; Agarwal A; Haines JL; Pericak-Vance MA; Postel EA
    Arch Ophthalmol; 2007 Jan; 125(1):63-7. PubMed ID: 17210853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration.
    Seddon JM; Reynolds R; Yu Y; Rosner B
    PLoS One; 2014; 9(1):e87047. PubMed ID: 24498017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.
    de Jong EK; Breukink MB; Schellevis RL; Bakker B; Mohr JK; Fauser S; Keunen JE; Hoyng CB; den Hollander AI; Boon CJ
    Ophthalmology; 2015 Mar; 122(3):562-70. PubMed ID: 25439433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration.
    Martínez-Barricarte R; Recalde S; Fernández-Robredo P; Millán I; Olavarrieta L; Viñuela A; Pérez-Pérez J; García-Layana A; Rodríguez de Córdoba S;
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1087-94. PubMed ID: 22247456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients.
    Losonczy G; Fekete Á; Vokó Z; Takács L; Káldi I; Ajzner É; Kasza M; Vajas A; Berta A; Balogh I
    Acta Ophthalmol; 2011 May; 89(3):255-62. PubMed ID: 19845562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy.
    Perlee LT; Bansal AT; Gehrs K; Heier JS; Csaky K; Allikmets R; Oeth P; Paladino T; Farkas DH; Rawlings PL; Hageman GS
    Ophthalmology; 2013 Sep; 120(9):1880-92. PubMed ID: 23523162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor H variant Y402H and basal laminar deposits in exudative age-related macular degeneration.
    Lommatzsch A; Hermans P; Weber B; Pauleikhoff D
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1713-6. PubMed ID: 17704937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.